Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.
作者信息
Turkmen D, Altunisik N
机构信息
Department of Dermatology, Inonu University, Malatya, Turkey.
出版信息
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e606. doi: 10.1111/jdv.18117. Epub 2022 Apr 22.
Abstract
摘要
相似文献
1
Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e606. doi: 10.1111/jdv.18117. Epub 2022 Apr 22.
2
Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.
Dermatol Ther. 2022 May;35(5):e15363. doi: 10.1111/dth.15363. Epub 2022 Feb 14.
3
Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e411-e415. doi: 10.1111/jdv.17965. Epub 2022 Feb 4.
4
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
5
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
6
Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes.
J Dermatol. 2022 Oct;49(10):e393-e394. doi: 10.1111/1346-8138.16442. Epub 2022 May 13.
7
Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine.
Eur J Dermatol. 2022 May 1;32(3):420-421. doi: 10.1684/ejd.2022.4285.
8
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.
J Korean Med Sci. 2022 Apr 25;37(16):e131. doi: 10.3346/jkms.2022.37.e131.
9
Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
Int J Rheum Dis. 2022 Mar;25(3):353-363. doi: 10.1111/1756-185X.14279. Epub 2022 Jan 3.
10
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
BMJ. 2022 Jul 13;378:e070483. doi: 10.1136/bmj-2022-070483.
引用本文的文献
1
Predicting herd immunity achievement: a time-series analysis of vaccination and fatality rates using 1,075 days of COVID-19 data.
Front Public Health. 2024 Sep 20;12:1403163. doi: 10.3389/fpubh.2024.1403163. eCollection 2024.
本文引用的文献
1
Exacerbations of generalized pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris after mRNA COVID-19 vaccine: A report of three cases.
Dermatol Ther. 2022 Apr;35(4):e15331. doi: 10.1111/dth.15331. Epub 2022 Feb 1.
2
Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine.
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e632-e634. doi: 10.1111/jdv.17449. Epub 2021 Jun 24.
3
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
4
Comparison of patients' diagnoses in a dermatology outpatient clinic during the COVID-19 pandemic period and pre-pandemic period.
Int J Clin Pract. 2021 Apr;75(4):e13948. doi: 10.1111/ijcp.13948. Epub 2020 Dec 26.
Zotero 插件